KR20230172322A - Sunscreen cosmetic compositions in aerosol form - Google Patents
Sunscreen cosmetic compositions in aerosol form Download PDFInfo
- Publication number
- KR20230172322A KR20230172322A KR1020220073050A KR20220073050A KR20230172322A KR 20230172322 A KR20230172322 A KR 20230172322A KR 1020220073050 A KR1020220073050 A KR 1020220073050A KR 20220073050 A KR20220073050 A KR 20220073050A KR 20230172322 A KR20230172322 A KR 20230172322A
- Authority
- KR
- South Korea
- Prior art keywords
- sunscreen
- aerosol
- cosmetic composition
- skin
- type
- Prior art date
Links
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 64
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 64
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 239000002537 cosmetic Substances 0.000 title claims abstract description 34
- 239000000443 aerosol Substances 0.000 title claims description 27
- 239000000839 emulsion Substances 0.000 claims abstract description 22
- 239000003915 liquefied petroleum gas Substances 0.000 claims abstract description 22
- 239000003380 propellant Substances 0.000 claims abstract description 9
- 239000004615 ingredient Substances 0.000 claims description 13
- 241000195940 Bryophyta Species 0.000 claims description 12
- 235000011929 mousse Nutrition 0.000 claims description 12
- 239000012071 phase Substances 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 8
- 230000003750 conditioning effect Effects 0.000 claims description 6
- 239000008346 aqueous phase Substances 0.000 claims description 5
- 229960005193 avobenzone Drugs 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 4
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 claims description 4
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 4
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 4
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 229960004881 homosalate Drugs 0.000 claims description 4
- 229920002674 hyaluronan Polymers 0.000 claims description 4
- 229960003160 hyaluronic acid Drugs 0.000 claims description 4
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 4
- 229960000601 octocrylene Drugs 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000011787 zinc oxide Substances 0.000 claims description 4
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 3
- 241000132536 Cirsium Species 0.000 claims description 3
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 3
- 229940106189 ceramide Drugs 0.000 claims description 3
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 3
- 229960001679 octinoxate Drugs 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims 1
- 229910052719 titanium Inorganic materials 0.000 claims 1
- 239000010936 titanium Substances 0.000 claims 1
- 239000006260 foam Substances 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 11
- 238000001816 cooling Methods 0.000 abstract description 9
- 230000014759 maintenance of location Effects 0.000 abstract description 6
- 238000005187 foaming Methods 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 39
- 230000000052 comparative effect Effects 0.000 description 31
- 238000012360 testing method Methods 0.000 description 19
- 230000000903 blocking effect Effects 0.000 description 14
- 206010040880 Skin irritation Diseases 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229960005196 titanium dioxide Drugs 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- -1 ethylhexyl Chemical group 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000036548 skin texture Effects 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229960001296 zinc oxide Drugs 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 208000002029 allergic contact dermatitis Diseases 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 230000035597 cooling sensation Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/24—Thermal properties
- A61K2800/244—Endothermic; Cooling; Cooling sensation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 거품 생성력이 우수하고, 사용감이 우수한 에어로졸 타입의 자외선차단용 화장료 조성물에 관한 것으로서, 본 발명에 따르면 선스크린(sunscreen) 유화물과 분사제로서 액화석유가스(LPG)를 포함하는 에어로졸 타입의 자외선차단용 화장료 조성물이 제공된다. 본 발명의 에어로졸 타입의 자외선차단용 화장료 조성물은 사용시 조밀하고 풍성한 거품을 생성하며, 거품 유지시간이 길어서 사용감이 우수하며 피부 쿨링효과도 우수하여 자외선 차단제로서 유용하게 사용될 수 있다.The present invention relates to an aerosol-type sunscreen cosmetic composition with excellent foaming ability and excellent feeling of use. According to the present invention, an aerosol-type cosmetic composition containing a sunscreen emulsion and liquefied petroleum gas (LPG) as a propellant is used. A cosmetic composition for sunscreen is provided. The aerosol-type sunscreen cosmetic composition of the present invention creates a dense and abundant foam when used, has a long foam retention time, provides an excellent feeling of use, and has an excellent skin cooling effect, so it can be usefully used as a sunscreen.
Description
본 발명은 에어로졸 자외선차단용 화장료 조성물에 관한 것으로서, 구체적으로는 백탁현상이 없고 사용감 및 자외선 차단 기능이 우수한 에어로졸 타입의 자외선 차단용 화장료 조성물에 관한 것이다.The present invention relates to an aerosol cosmetic composition for blocking ultraviolet rays, and more specifically, to an aerosol-type cosmetic composition for blocking ultraviolet rays that does not cause white clouding and has excellent feeling of use and excellent ultraviolet ray blocking function.
자외선은 그 파장에 따라 UVA(320 - 400 nm), UVB(290 - 320 nm) 및 UVC(200 - 290nm)로 분류된다. 이들 자외선은 사람의 피부에 흡수된 후 피부 세포 및 조직을 손상시킴으로써 피부 노화를 가속화시킬 수 있다. 보다 짧은 파장의 자외선인 UVB는 표피에 흡수되어 표피의 구성 성분들에 대한 산화적 손상을 가져온다. 반면 장파장의 UVA는 UVB와는 달리 피부의 진피까지 침투할 수 있다. 진피에서 UVA는 활성산소종의 생성을 경유하는 광화학적 반응을 통하여 직접적으로 세포외 기질(extracellular matrix, ECM) 성분인 콜라겐, 엘라스틴, 히알루론산 및 글라이코사미노글리칸 등 생체 고분자의 사슬을 절단 파괴시키거나 또는 콜라겐 분해효소(matrix metalloproteases, MMPs)의 발현을 증가시킴으로써 피부노화를 가속화시킬 수 있다. Ultraviolet rays are classified according to their wavelength into UVA (320 - 400 nm), UVB (290 - 320 nm), and UVC (200 - 290 nm). These ultraviolet rays can accelerate skin aging by damaging skin cells and tissues after being absorbed into human skin. UVB, which is shorter wavelength ultraviolet rays, is absorbed by the epidermis and causes oxidative damage to the components of the epidermis. On the other hand, unlike UVB, long-wavelength UVA can penetrate into the dermis of the skin. In the dermis, UVA directly cuts the chains of biopolymers such as collagen, elastin, hyaluronic acid, and glycosaminoglycan, which are components of the extracellular matrix (ECM), through a photochemical reaction that generates reactive oxygen species. Skin aging can be accelerated by destroying collagen or increasing the expression of matrix metalloproteases (MMPs).
뿐만 아니라 자외선으로 유도된 활성산소종은 멜라닌 생성과정에도 참여하여 과도한 멜라닌 생성에 기인하는 기미, 주근깨 등의 색소침착을 일으킨다. 이에 따라 자외선을 차단/흡수할 수 있는 자외선 차단제의 사용이 증가되고 있다. 자외선차단제는 유기 자외선차단제와 무기 자외선차단제로 구분된다.In addition, reactive oxygen species induced by ultraviolet rays also participate in the melanin production process, causing pigmentation such as spots and freckles due to excessive melanin production. Accordingly, the use of sunscreens that can block/absorb ultraviolet rays is increasing. Sunscreens are divided into organic sunscreens and inorganic sunscreens.
산화아연과 이산화티탄으로 대표되는 무기 자외선차단제는 자외선을 물리적으로 산란시켜 자외선으로부터 피부를 보호한다. 이에 대하여 유기 자외선차단제는 옥시벤존(Oxybenzone), 아보벤존(Avobenzone) 등 벤젠 계열의 유기화학물질이 주성분을 이루며, 이 성분들이 자외선을 흡수해 피부에 침투되는 것을 막는 방식의 자외선 차단제이다.Inorganic sunscreens, such as zinc oxide and titanium dioxide, protect the skin from ultraviolet rays by physically scattering ultraviolet rays. In contrast, organic sunscreen is a sunscreen that mainly consists of benzene-based organic chemicals such as oxybenzone and avobenzone, and these ingredients absorb ultraviolet rays and prevent them from penetrating the skin.
무기 자외선차단제는 피부에 대하여 안전성이 높다는 장점이 있지만, 백탁 현상이 발생할 수 있다는 단점을 가진다. 이에 대하여 유기 자외선차단제는 무겁고 번들거리는 등의 사용감 저하의 문제가 있으며, 접촉성 알레르기 피부염을 유발할 수도 있다는 문제점을 가진다.Inorganic sunscreens have the advantage of being highly safe for the skin, but have the disadvantage of causing a white cast phenomenon. In contrast, organic sunscreens have the problem of deteriorating the feeling of use, such as being heavy and shiny, and may cause contact allergic dermatitis.
종래 자외선 차단제는 크림, 로션 등의 유화물이나, 무스나 스프레이 타입의 에어로졸 형태로 제조되어 왔다. 크림, 로션 제형은 유기 자외선 차단제와 무기 자외선 차단제를 병용하기에 유리하고, 자외선 차단효과가 우수하다는 장점을 가지지만, 사용감이 무겁거나 뻑뻑하고 백탁현상을 발생시키는 문제점이 있었으며, 스프레이 타입은 가벼운 사용감이 특징이지만 자외선 차단제를 많이 함유하지 못하게 되는 문제점이 있었다.Conventionally, sunscreens have been manufactured in the form of emulsions such as creams and lotions, or in the form of mousse or spray-type aerosols. Cream and lotion formulations are advantageous for using organic and inorganic sunscreens in combination, and have the advantage of excellent UV blocking effect, but they have the problem of feeling heavy or sticky and causing a white cast, while spray types have a light feeling when used. Despite this feature, there was a problem in that it did not contain a lot of sunscreen.
무스 타입의 에어로졸 제품은 내용물이 거품형태로 분사되어 얼굴뿐만 아니라 넓은 면적의 피부에 쉽게 펴 바를 수 있으며 사용감이 좋다는 장점을 가지지만, 거품 생성이 어렵고 거품이 쉽게 흘러내려서 유지시간을 확보하기 어려운 문제가 있었다.Mousse-type aerosol products have the advantage that the contents are sprayed in the form of a foam, so they can be easily spread not only on the face but also on a large area of skin, and they have a good feeling of use. However, it is difficult to create foam and the foam flows off easily, making it difficult to secure retention time. There was.
이에 본 발명자들은 조밀하고 풍성한 거품을 형성하고 그 거품 유지시간이 장기간 유지되어 사용감이 우수하며 자외선 차단활성도 우수한 에어로졸 타입의 자외선차단용 화장료 조성물을 제조하기 위하여 노력하였으며 이에 본 발명을 완성하였다. Accordingly, the present inventors tried to prepare an aerosol-type sunscreen cosmetic composition that forms a dense and abundant foam, maintains the foam for a long time, provides an excellent feeling of use, and has excellent ultraviolet ray blocking activity, and thus completed the present invention.
본 발명은 거품 생성력이 우수하고, 사용감이 우수한 에어로졸 타입의 자외선차단용 화장료 조성물을 제공하는 것을 목적으로 한다.The purpose of the present invention is to provide an aerosol type cosmetic composition for sunscreen with excellent foaming ability and excellent feeling of use.
상기 과제를 달성하기 위하여 본 발명에 따르면 선스크린(sunscreen) 유화물과 분사제로서의 액화석유가스(LPG)를 포함하는 에어로졸 타입의 자외선차단용 화장료 조성물이 제공된다.In order to achieve the above object, according to the present invention, an aerosol type sunscreen cosmetic composition is provided including a sunscreen emulsion and liquefied petroleum gas (LPG) as a propellant.
이때, 상기 선스크린(sunscreen) 유화물과 액화석유가스(LPG)는 각각 80~85중량%, 15~20중량%의 비율로 함유되는 것임을 특징으로 한다.At this time, the sunscreen emulsion and liquefied petroleum gas (LPG) are characterized in that they are contained in a ratio of 80 to 85% by weight and 15 to 20% by weight, respectively.
상기 선스크린(sunscreen) 유화물은 자외선 차단제와 유화제로 이루어지는 유상부와 용제, 점증제 및 피부컨디셔닝 성분으로 이루어지는 수상부를 포함하여 이루어지는 것임을 특징으로 한다. 상기 자외선 차단제는 부틸메톡시디벤조일메탄, 비스-에칠헥실옥시페놀메톡시페닐트리아진, 호모살레이트, 에칠헥실살리실레이트, 에칠헥실메톡시신나메이트, 옥토크릴렌, 티타늄디옥사이드 및 징크옥사이드로 이루어지는 군으로부터 선택되는 적어도 하나인 것을 특징으로 한다. 상기 피부컨디셔닝 성분은 글리세린, 세라마이드, 히알루론산, 펩타이드 및 고려엉겅퀴잎추출물로 이루어지는 군으로부터 선택되는 적어도 하나인 것을 특징으로 한다.The sunscreen emulsion is characterized by comprising an oil phase composed of a sunscreen and an emulsifier and an aqueous phase composed of a solvent, thickener, and skin conditioning ingredient. The sunscreen consists of butylmethoxydibenzoylmethane, bis-ethylhexyloxyphenolmethoxyphenyltriazine, homosalate, ethylhexyl salicylate, ethylhexyl methoxycinnamate, octocrylene, titanium dioxide and zinc oxide. It is characterized in that it is at least one selected from the group. The skin conditioning ingredient is characterized in that it is at least one selected from the group consisting of glycerin, ceramide, hyaluronic acid, peptide, and Korean thistle leaf extract.
상기 에어로졸 타입의 자외선차단용 화장료 조성물은 무스형인 것을 특징으로 한다.The aerosol type cosmetic composition for sunscreen is characterized in that it is mousse type.
본 발명의 에어로졸 타입의 자외선차단용 화장료 조성물은 사용시 조밀하고 풍성한 거품을 생성하며, 거품 유지시간이 길어서 사용감이 우수하며 피부 쿨링효과도 우수하여 자외선 차단제로서 유용하게 사용될 수 있다. The aerosol-type sunscreen cosmetic composition of the present invention creates a dense and abundant foam when used, has a long foam retention time, provides an excellent feeling of use, and has an excellent skin cooling effect, so it can be usefully used as a sunscreen.
도 1은 본 발명 실시예 및 비교예의 에어로졸 자외선차단용 화장료 조성물의 무스 거품 시험결과를 나타내는 사진도이다.Figure 1 is a photograph showing the mousse foam test results of the aerosol sunscreen cosmetic compositions of Examples and Comparative Examples of the present invention.
이하, 본 발명을 더욱 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명에 따르면 선스크린(sunscreen) 유화물과 분사제로서 액화석유가스(LPG)를 포함하는 에어로졸 타입의 자외선차단용 화장료 조성물이 제공된다.According to the present invention, an aerosol type sunscreen cosmetic composition containing a sunscreen emulsion and liquefied petroleum gas (LPG) as a propellant is provided.
이때, 상기 선스크린(sunscreen) 유화물과 액화석유가스(LPG)는 각각 80~85중량%, 15~20중량%의 비율로 함유된다. 상기 선스크린(sunscreen) 유화물과 액화석유가스(LPG)는 각각 80:20 중량%의 비율로 이루어지는 경우에 더욱 우수한 거품 생성 능력 및 유지시간을 나타내므로 더욱 바람직하다.At this time, the sunscreen emulsion and liquefied petroleum gas (LPG) are contained in ratios of 80 to 85% by weight and 15 to 20% by weight, respectively. It is more preferable that the sunscreen emulsion and liquefied petroleum gas (LPG) are used in a ratio of 80:20% by weight, as they exhibit better foam generation ability and retention time.
상기 선스크린(sunscreen) 유화물은 자외선 차단제와 유화제로 이루어지는 유상부와 용제, 점증제 및 피부컨디셔닝 성분으로 이루어지는 수상부를 포함하여 이루어 진다. The sunscreen emulsion includes an oil phase composed of a sunscreen and an emulsifier, and an aqueous phase comprised of a solvent, thickener, and skin conditioning ingredient.
상기 자외선 차단제는 유화물 전체 중량에 대하여 20~40중량%의 비율로 함유되며, 부틸메톡시디벤조일메탄, 비스-에칠헥실옥시페놀메톡시페닐트리아진, 호모살레이트, 에칠헥실살리실레이트, 에칠헥실메톡시신나메이트, 옥토크릴렌, 티타늄디옥사이드 및 징크옥사이드로 이루어지는 군으로부터 선택되는 적어도 하나가 사용될 수 있다.The sunscreen is contained in a ratio of 20 to 40% by weight based on the total weight of the emulsion, and includes butylmethoxydibenzoylmethane, bis-ethylhexyloxyphenolmethoxyphenyltriazine, homosalate, ethylhexyl salicylate, and ethylhexyl. At least one selected from the group consisting of silmethoxycinnamate, octocrylene, titanium dioxide, and zinc oxide may be used.
상기 유화제로는 폴리솔베이트가 사용될 수 있으며, 바람직하게는 폴리솔베이트 20이 사용될 수 있다.Polysorbate may be used as the emulsifier, preferably polysorbate 20.
상기 피부컨디셔닝 성분은 유화물 전체 중량에 대하여 0.1~20중량% 함유되며, 글리세린, 세라마이드, 히알루론산, 펩타이드 및 고려엉겅퀴잎추출물로 이루어지는 군으로부터 선택되는 적어도 하나가 사용될 수 있다.The skin conditioning ingredient is contained in an amount of 0.1 to 20% by weight based on the total weight of the emulsion, and at least one selected from the group consisting of glycerin, ceramide, hyaluronic acid, peptide, and Korean thistle leaf extract may be used.
본 발명의 일 구체예에 따르면 상기 점증제로서 잔탄검, 아크릴레이트/C10-30알킬아크릴레이트크로스폴리머 등이 사용될 수 있으며, 용제로는 바람직하게는 물이 사용된다.According to one embodiment of the present invention, xanthan gum, acrylate/C10-30 alkyl acrylate crosspolymer, etc. may be used as the thickener, and water is preferably used as the solvent.
상기 선스크린(sunscreen) 유화물에는 상기 성분들 외에 필요에 따라 pH 조절제, 점증제, 보존제, 색소, 향료 등의 통상의 화장료가 포함될 수 있다.In addition to the above ingredients, the sunscreen emulsion may contain conventional cosmetics such as pH adjusters, thickeners, preservatives, pigments, and fragrances, as needed.
상기 선스크린 유화물은 통상의 제조방법에 따라 제조된다. 본 발명의 일 구체예에 따르면 수상 및 유상 성분을 75℃에서 각각 용해 및 분산시킨다. 이어서, 수상에 유상을 천천히 첨가 후 교반하여 수중유형(O/W) 유화물을 제조한다. The sunscreen emulsion is manufactured according to a conventional manufacturing method. According to one embodiment of the present invention, the water phase and oil phase components are respectively dissolved and dispersed at 75°C. Next, the oil phase is slowly added to the water phase and stirred to prepare an oil-in-water (O/W) emulsion.
본 발명의 에어로졸 제형의 화장료 조성물의 제조에는 분사제(propellant)로서 액화석유가스(LPG)가 사용된다. 본 발명의 일 구체예에 따르면 상기 LPG는 프로판(C3)과 부탄(C4)가 각각 30wt% : 70wt%의 조성으로 이루어진 것을 사용한다.In the production of the aerosol cosmetic composition of the present invention, liquefied petroleum gas (LPG) is used as a propellant. According to one embodiment of the present invention, the LPG is used in a composition of 30 wt% and 70 wt% of propane (C3) and butane (C4), respectively.
상기 제조된 선스크린 유화물을 내압 용기에 넣고, 분사제를 주입하여 무스형의 에어로졸 타입의 자외선차단용 화장료 조성물을 제조한다.The prepared sunscreen emulsion is placed in a pressure-resistant container, and a propellant is injected to prepare a mousse-type aerosol-type sunscreen cosmetic composition.
이와 같이 제조되는 에어로졸 타입의 자외선차단용 화장료 조성물은 무스 거품 생성력이 우수하였으며, 그 유지시간도 장시간 유지되고(시험예 1), 사용감이 우수하였다(시험예 2). 또한, 피부 쿨링효과를 나타내어 피부진정에도 우수한 효과를 나타내었으며(시험예 3), 자외선 차단효과도 우수하였다(시험예 4)..The aerosol-type sunscreen cosmetic composition prepared in this way had excellent mousse foam generation ability, maintained for a long time (Test Example 1), and had an excellent feeling of use (Test Example 2). In addition, it showed a skin cooling effect and was excellent at soothing the skin (Test Example 3), and also had an excellent UV blocking effect (Test Example 4).
[실시예][Example]
이하, 본 발명을 실시예 및 시험예를 통하여 더욱 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail through examples and test examples.
제조예 1: 선스크린(sunscreen) 유화물의 제조Preparation Example 1: Preparation of sunscreen emulsion
하기 표 1의 조성에 따라 선스크린 유화물을 제조하였다.A sunscreen emulsion was prepared according to the composition in Table 1 below.
교반조에 수상성분의 원료들을 넣고 75℃로 가온 후, 호모믹싱하여 균일화하여 수상 교반조를 준비하였다. 다른 교반조에 유상성분의 원료들을 넣고 75℃로 가온하여 완전 용해시켜 유상 교반조를 준비하였다. 상기 준비된 수상 교반조에 유상 교반조 내 유상 원료 혼합물을 투입하고 5분간 균일 유화시켰다. 상기 얻어진 유화물을 45℃로 냉각 후, 기타 원료들을 넣고 3분간 균일 분산시켰다. 상기 얻어진 결과물을 30℃로 냉각시킨 후, 유백색의 로션상(O/W)의 조성물을 얻었다.The aqueous phase ingredients were placed in a stirring tank, heated to 75°C, homomixed to homogenize, and an aqueous phase stirring tank was prepared. The oil phase ingredients were placed in another stirring tank, heated to 75°C, and completely dissolved to prepare an oil phase stirring tank. The oil phase raw material mixture in the oil phase stirring tank was added to the prepared water phase stirring tank and uniformly emulsified for 5 minutes. After cooling the obtained emulsion to 45°C, other raw materials were added and uniformly dispersed for 3 minutes. After cooling the obtained result to 30°C, a milky white lotion-like (O/W) composition was obtained.
실시예, 비교예 1~5: 에어로졸 자외선차단용 화장료 조성물의 제조Examples, Comparative Examples 1 to 5: Preparation of aerosol cosmetic composition for sunscreen
하기 표 2의 조성에 따라 에어로졸 타입의 자외선차단용 화장료 조성물을 제조하였다.An aerosol-type sunscreen cosmetic composition was prepared according to the composition in Table 2 below.
상기 제조된 선스크린 유화물을 내압용기에 넣고, 분사제인 LPG(C3:C4=30:70wt%)를 하기 표 2의 조성에 따라 주입하여 무스형 자외선차단용 화장료 조성물을 제조하였다. 분사제인 LPG의 사용비율을 달리한 것과 분사제로서 Dimethyl Ether를 사용하여 제조한 것을 비교예로 하였다. The sunscreen emulsion prepared above was placed in a pressure-resistant container, and LPG (C3:C4=30:70wt%) as a propellant was injected according to the composition in Table 2 below to prepare a mousse-type sunscreen cosmetic composition. As a comparative example, products manufactured using different ratios of LPG as a propellant and those manufactured using Dimethyl Ether as a propellant were used.
(제조예 1)emulsion
(Production Example 1)
시험예 1: 무스 거품 시험Test Example 1: Mousse Foam Test
상기 실시예 및 비교예의 에어로졸 자외선차단용 화장료 조성물의 무스 거품 생성 여부 및 유지시간을 측정하였다. The creation and retention time of mousse foam of the aerosol sunscreen cosmetic compositions of the above Examples and Comparative Examples were measured.
본 시험은 자발적으로 모집된 평균 30세 이상의 3명의 여성에 대하여 수행하였다. 피험자가 동일한 세안제(㈜파이온텍)로 세안하고, 30분간 항온습실(온도: 22±1℃, 습도: 40±5%)에서 안정을 취하게 한 후, 실시예 및 비교예 1 내지 5의 에어로졸 자외선 차단용 화장료 조성물의 적당량을 피험자의 왼쪽 안면 부위에 적용하였다. 무스 거품의 생성 여부를 관찰하고 무스 거품의 유지시간을 각각 측정하였으며, 그 결과를 하기 표 3 및 도 1에 나타내었다.This study was conducted on three voluntarily recruited women with an average age of over 30 years. After the subject washed his face with the same face wash (Piontech Co., Ltd.) and rested in a constant temperature and humidity room (temperature: 22 ± 1°C, humidity: 40 ± 5%) for 30 minutes, the aerosol of Examples and Comparative Examples 1 to 5 An appropriate amount of the cosmetic composition for sunscreen was applied to the subject's left facial area. The formation of mousse foam was observed and the retention time of the mousse foam was measured, and the results are shown in Table 3 and Figure 1 below.
상기 표 3 및 도 1에서 확인되는 바와 같이 실시예의 에어로졸 조성물은 거품 생성 능력이 우수하고, 유용한 효과를 나타내는 기능성 성분이 피부흡수 및/또는 피부 쿨링 효과를 나타내기에 충분한 시간동안 무스 거품을 유지함을 보여준다.As seen in Table 3 and Figure 1, the aerosol composition of the example has excellent foaming ability, and the functional ingredients showing useful effects maintain the mousse foam for a sufficient period of time to provide skin absorption and/or skin cooling effect. .
시험예 2: 사용감 시험Test Example 2: Usability test
상기 실시예 및 비교예 1 내지 5에서 제조된 에어로졸 화장료 조성물의 사용감을 평가하였다. 본 시험은 30세 내지 40세의 10명의 여성을 대상으로 다음의 방법으로 수행하였다.The feeling of use of the aerosol cosmetic compositions prepared in Examples 1 to 5 was evaluated. This test was conducted on 10 women aged 30 to 40 using the following method.
세안 후 토너를 사용하여 피부결을 정돈한 후, 실시예 및 비교예 1 내지 5의 조성물을 2회 펌핑의 양으로 덜어 피부결에 따라 얼굴 전체에 도포하여 흡수시켜 사용하였다. 사용감 시험을 위하여, 흡수력, 끈적임, 촉촉함, 발림성, 피부자극도 및 전체적인 만족도의 7개의 항목에 대한 평가를 수행하였다. 각 항목에 대하여 최대 5점에서 최하 0점(피부 자극도를 제외한 항목: 점수가 높을수록 만족도가 좋음; 피부 자극도: 점수가 낮을수록 피부 자극도가 낮음)으로 평가하였다.After washing the face and adjusting the skin texture using toner, the compositions of Examples and Comparative Examples 1 to 5 were applied in two pump amounts and applied to the entire face according to the skin texture and allowed to be absorbed. For the usability test, seven items of absorption, stickiness, moisture, spreadability, skin irritation, and overall satisfaction were evaluated. Each item was evaluated from a maximum of 5 to a minimum of 0 (items excluding skin irritation: the higher the score, the better the satisfaction; skin irritation: the lower the score, the lower the skin irritation).
그 결과를 하기 표 4에 나타내었다.The results are shown in Table 4 below.
상기 표 4에서 확인되는 바와 같이 실시예의 에어로졸 조성물이 비교예 1 내지 5와 비교하여, 흡수력, 촉촉함 및 발림성이 우수하고, 끈적임과 피부 자극도가 적으며, 전체적인 만족도가 우수한 것으로 나타났다.As confirmed in Table 4, compared to Comparative Examples 1 to 5, the aerosol composition of the example showed excellent absorption, moisture, and spreadability, less stickiness and less skin irritation, and excellent overall satisfaction.
시험예 3: 피부 쿨링감 시험Test Example 3: Skin cooling sensation test
에어로졸 자외선차단용 화장료 조성물이 피부 온도에 미치는 영향을 시험하기 위하여, 피부 적외선 체온계를 이용하여 1 일간 다음의 방법으로 에어로졸 자외선차단용 조성물 적용시의 피부 온도 변화를 측정하였다. In order to test the effect of the aerosol sunscreen cosmetic composition on skin temperature, the change in skin temperature when applying the aerosol sunscreen composition was measured using a skin infrared thermometer for one day using the following method.
본 시험은 자발적으로 모집된 평균 30세 이상의 3명의 여성에 대하여 수행하였다. 피험자가 동일한 세안제(㈜파이온텍)로 세안하고, 30분간 항온습실(온도: 22±1℃, 습도: 40±5%)에서 안정을 취하게 한 후, 실시예 및 비교예 1 내지 5의 에어로졸 조성물의 적당량을 피험자의 왼쪽 안면 부위에 적용하였다.This study was conducted on three voluntarily recruited women with an average age of over 30 years. After the subject washed his face with the same face wash (Piontech Co., Ltd.) and rested in a constant temperature and humidity room (temperature: 22 ± 1°C, humidity: 40 ± 5%) for 30 minutes, the aerosol of Examples and Comparative Examples 1 to 5 An appropriate amount of the composition was applied to the subject's left facial area.
에어로졸 조성물의 사용 전과 사용 직후의 피부온도를 측정하였다. 구체적으로는 맨 얼굴 상태에서 적외선 체온계를 이용하여 2~3cm 거리에서 왼쪽 안면 부위 피부 온도를 측정하였다. 상기 맨 얼굴의 피부 온도 측정 시로부터 1분 후에 실시예 및 비교예 1 내지 5의 에어로졸 조성물을 피험자의 왼쪽 안면 부위에 1g 용량으로 고르게 도포하고, 10초 후 적외선 체온계를 이용하여 2~3cm 거리에서 왼쪽 안면의 도포 부위의 온도를 측정하였다. 그 결과를 하기 표 5에 나타내었다.Skin temperature was measured before and immediately after using the aerosol composition. Specifically, the skin temperature of the left facial area was measured from a distance of 2 to 3 cm using an infrared thermometer with a bare face. One minute after measuring the skin temperature of the bare face, the aerosol compositions of Examples and Comparative Examples 1 to 5 were evenly applied to the left facial area of the subject in a dose of 1 g, and after 10 seconds, the aerosol composition was applied at a distance of 2 to 3 cm using an infrared thermometer. The temperature of the application area on the left face was measured. The results are shown in Table 5 below.
비교예 1에서는 도포 전과 비교시 피부 온도 변화가 거의 없어 피부 쿨링 효과를 기대할 수 없었으며, 비교예 2 내지 5에서는 도포 전과 비교시 피부 온도가 약 10℃ 이상 급격히 하강하는 것을 확인할 수 있다. 반면, 실시예에서는 약 4℃ 정도 피부온도가 하강하였다. In Comparative Example 1, there was little change in skin temperature compared to before application, so a skin cooling effect could not be expected, and in Comparative Examples 2 to 5, it was confirmed that the skin temperature rapidly decreased by about 10°C or more compared to before application. On the other hand, in the example, the skin temperature decreased by about 4°C.
피부 온도를 낮추는 것은 피부 탄력 저하나 모공 늘어짐 등의 현상을 막는 근본적인 피부 관리 방법이다. 피부 쿨링 효과가 있는 화장품으로 피부 온도를 낮추면 피부를 진정시켜 피부 속 염증을 완화시키는 데에도 매우 효과적이다. 다만, 피부 온도가 지나치게 낮아지면 오히려 혈액순환과 피부 활동이 둔화되므로, 피부 온도를 무조건 낮추는 것이 최선은 아니다. 이렇듯 적절한 수준의 피부 쿨링 효과가 중요하다는 점에 비추어볼 때, 피부 온도가 약 4℃ 정도 하강한 실시예의 조성물이 피부에 가장 좋은 효과를 가져 올 수 있음을 확인할 수 있다.Lowering skin temperature is a fundamental skin care method that prevents phenomena such as loss of skin elasticity or sagging pores. This cosmetic product has a skin cooling effect and is very effective in soothing the skin and relieving inflammation in the skin by lowering the skin temperature. However, if the skin temperature drops too low, blood circulation and skin activity slows down, so it is not best to lower the skin temperature unconditionally. In light of the importance of an appropriate level of skin cooling effect, it can be confirmed that the composition of the example where the skin temperature is lowered by about 4°C can bring about the best effect on the skin.
시험예 4: PA, SPF 지수 측정Test Example 4: PA, SPF index measurement
상기 제조된 실시예의 자외선 차단용 조성물에 대하여 자외선차단지수 평가를 위한 인체적용시험을 실시하였다.A human application test was conducted to evaluate the UV protection index of the UV blocking composition prepared above.
자외선 A 차단등급(PA)은 UVA의 차단효과의 정도를 나타내는 것이다. 일정 면적의 인체피부를 두 부위로 나누어 한 쪽 부위에는 자외선차단용 조성물 일정량을 도포하고 한 쪽 부위에는 자외선 차단용 조성물을 도포하지 않는다. 일정 광량의 자외선을 일정 간격으로 자외선 차단용 조성물 도포부위와 도포하지 않은 부위에 조사한 후, 조사영역의 전 영역에 희미한 흑화가 인식되는 최소 자외선 조사량인 최소지속형즉시흑화량(Minimal Persistent Pigment darkening Dose, MPPD)을 측정하고 비교하여 자외선 차단정도를 평가한다.The UVA protection grade (PA) indicates the degree of UVA blocking effect. A certain area of human skin is divided into two parts, and a certain amount of UV blocking composition is applied to one part, and no UV blocking composition is applied to one part. After irradiating a certain amount of ultraviolet rays at regular intervals to the area where the ultraviolet ray blocking composition has been applied and to the area where the composition has not been applied, the Minimum Persistent Pigment darkening Dose is the minimum amount of ultraviolet irradiation at which faint darkening is recognized in the entire irradiated area. , MPPD) is measured and compared to evaluate the degree of UV protection.
자외선차단지수(SPF)는 UVB를 차단하는 제품의 차단효과를 나타내는 지수로서 자외선차단용 조성물을 도포하여 얻은 최소홍반량을 자외선차단용 조성물을 도포하지 않고 얻은 최소홍반량으로 나눈 값이다. 최소홍반량(Minimum Erythema Dose, MED)이라 함은 UVB를 사람의 피부에 조사한 후 16∼24시간의 범위 내에, 조사영역의 전 영역에 홍반을 나타낼 수 있는 최소한의 자외선 조사량을 말한다.The sun protection factor (SPF) is an index indicating the blocking effect of a product that blocks UVB, and is calculated by dividing the minimum amount of erythema obtained by applying a sunscreen composition by the minimum amount of erythema obtained without applying a sunscreen composition. Minimum Erythema Dose (MED) refers to the minimum amount of UV radiation that can cause erythema to appear in the entire irradiated area within 16 to 24 hours after UVB is irradiated to human skin.
구체적인 시험법은 식품의약품안전처 고시 제2021-55호의 '자외선 차단효과 측정방법 및 기준'에 따랐다. 식품의약품안전처 고시 제2021-55호의 기능성화장품 심사에 관한 규정 [부표 1] 자외선 차단효과 측정방법 및 기준에 따라 피부유형 II, III형인 시험 대상자 10명을 대상으로 인체적용시험을 실시하였으며, 그 결과를 하기 표 6에 나타내었다. The specific test method was in accordance with the Ministry of Food and Drug Safety Notice No. 2021-55, ‘Method and Standard for Measurement of UV Blocking Effect’. A human application test was conducted on 10 test subjects with skin types II and III in accordance with the regulations on the screening of functional cosmetics in the Ministry of Food and Drug Safety Notice No. 2021-55 [Appendix 1] UV blocking effect measurement methods and standards. The results are shown in Table 6 below.
Claims (6)
The aerosol type cosmetic composition for sunscreening according to claim 1, wherein the aerosol type cosmetic composition for sunscreening is in a mousse type.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220073050A KR20230172322A (en) | 2022-06-15 | 2022-06-15 | Sunscreen cosmetic compositions in aerosol form |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220073050A KR20230172322A (en) | 2022-06-15 | 2022-06-15 | Sunscreen cosmetic compositions in aerosol form |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230172322A true KR20230172322A (en) | 2023-12-22 |
Family
ID=89309705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220073050A KR20230172322A (en) | 2022-06-15 | 2022-06-15 | Sunscreen cosmetic compositions in aerosol form |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230172322A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101408631B1 (en) | 2007-04-17 | 2014-06-17 | 주식회사 엘지생활건강 | Mousse form cosmetic composition containing organic uv filters |
KR101684909B1 (en) | 2010-11-26 | 2016-12-09 | (주)아모레퍼시픽 | Spray type aerosol cosmetic composition |
KR102394637B1 (en) | 2015-09-30 | 2022-05-09 | (주)아모레퍼시픽 | Aerosol type composition for preventing hair loss or promoting hair growth |
-
2022
- 2022-06-15 KR KR1020220073050A patent/KR20230172322A/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101408631B1 (en) | 2007-04-17 | 2014-06-17 | 주식회사 엘지생활건강 | Mousse form cosmetic composition containing organic uv filters |
KR101684909B1 (en) | 2010-11-26 | 2016-12-09 | (주)아모레퍼시픽 | Spray type aerosol cosmetic composition |
KR102394637B1 (en) | 2015-09-30 | 2022-05-09 | (주)아모레퍼시픽 | Aerosol type composition for preventing hair loss or promoting hair growth |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101342292B1 (en) | Cosmetic composition for sun protection | |
KR101962952B1 (en) | Self-foaming cosmetic composition and method of preparing the same | |
CN110559197A (en) | Sunscreen lotion and preparation method thereof | |
KR102524749B1 (en) | A composition for spray mousse type sunscreen | |
KR20090070454A (en) | Chemical uv filter free sunscreen composition | |
BR102012000372B1 (en) | aqueous sunscreen cosmetic composition and use thereof, cosmetic method for applying said sunscreen, cosmetic method for preventing and controlling skin greasiness, cosmetic method for protecting the skin from damage caused by ultraviolet radiation, and cosmetic product | |
KR20130069512A (en) | Skin external composition comprising tangeretin | |
KR101408631B1 (en) | Mousse form cosmetic composition containing organic uv filters | |
CN108014060B (en) | Sunscreen synergistic composition and application thereof | |
CN113425649A (en) | Sunscreen synergistic composition, cosmetic composition and preparation method thereof | |
KR20190142655A (en) | Cosmetic composition containg nanoemulsion encapsulated with 7-dehydrocholesterol, cholesterol and stearic acid in inner phase of hyaluronate-ceramide NP complex | |
CN106333886B (en) | Composition with moisturizing, whitening and skin-brightening effects and application thereof | |
KR102638453B1 (en) | Surfactant-free liquid cosmetic composition for uv blocking | |
CN115024994B (en) | High-safety sun-screening composition and preparation method and application thereof | |
KR20060024612A (en) | Sheet type sun block product | |
KR20230172322A (en) | Sunscreen cosmetic compositions in aerosol form | |
EP3283135B1 (en) | Composition for covering and protecting scars | |
CN108498363A (en) | The SPF enhancer compositions and preparation method thereof that antiultraviolet effect is improved | |
KR20220034071A (en) | Cosmetic composition for anti-aging | |
KR102215331B1 (en) | Laser treatment for pain relief How to make cosmetics For pain application | |
DE10000840A1 (en) | Use of one or more nitric oxide synthase inhibitors e.g. nitroarginine in cosmetic and dermatological compositions for the treatment and prevention of intrinsic and/or extrinsic skin ageing | |
KR20090056390A (en) | Multiphase cosmetic composition containing uv blocking agents | |
KR20240025324A (en) | A composition for spray mousse type sunscreen | |
EP3395410B1 (en) | A cosmetic composition, method and process of application thereof | |
KR100886612B1 (en) | Tissue comprising composition for preventing ultraviolet rays and disposable tissue product packing the same |